Histogen Total Liab vs Non Currrent Assets Other Analysis

HSTO Stock

USD 0.02 0.01 25.65%

Histogen financial indicator trend analysis is much more than just examining Histogen latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Histogen is a good investment. Please check the relationship between Histogen Total Liab and its Non Currrent Assets Other accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.

Total Liab vs Non Currrent Assets Other

Total Liab vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Histogen Total Liab account and Non Currrent Assets Other. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Histogen's Total Liab and Non Currrent Assets Other is 0.56. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Histogen, assuming nothing else is changed. The correlation between historical values of Histogen's Total Liab and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Histogen are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Total Liab i.e., Histogen's Total Liab and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

0.56

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Most indicators from Histogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Histogen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.At this time, Histogen's Selling General Administrative is very stable compared to the past year. As of the 29th of November 2024, Sales General And Administrative To Revenue is likely to grow to 4.44, though Issuance Of Capital Stock is likely to grow to (8.6 K).

	2023	2024 (projected)
Total Revenue	19K	18.1K
Interest Income	653.2K	685.9K

Total Revenue Interest Income

Histogen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Other Assets	Long Term Debt	Long Term Debt Total
Total Assets		0.1	0.68	0.71	0.66	-0.62	-0.4	-0.19	0.18	0.45	-0.49	0.25	0.98	0.4	0.17	0.78	-0.03	-0.04	0.29	0.41	-0.6	0.98	-0.38	-0.19	0.72	-0.31
Short Long Term Debt Total	0.1		0.45	0.24	-0.13	0.38	0.18	-0.35	-0.31	0.06	0.54	0.69	0.01	-0.02	-0.35	-0.02	0.25	0.05	0.36	0.28	0.38	0.03	0.37	0.1	0.46	0.48
Other Current Liab	0.68	0.45		0.88	0.07	-0.41	-0.36	-0.74	-0.27	0.49	-0.15	0.75	0.62	0.73	-0.13	0.38	0.38	0.3	0.71	0.75	-0.4	0.66	-0.07	-0.08	0.82	0.3
Total Current Liabilities	0.71	0.24	0.88		0.02	-0.37	-0.72	-0.68	-0.21	0.8	-0.15	0.65	0.65	0.67	-0.22	0.24	0.43	0.17	0.64	0.85	-0.37	0.69	-0.03	-0.05	0.91	0.35
Total Stockholder Equity	0.66	-0.13	0.07	0.02		-0.39	0.05	0.28	0.44	-0.08	-0.42	-0.23	0.68	-0.24	0.51	0.77	-0.71	0.0	-0.04	-0.4	-0.37	0.67	-0.43	-0.08	0.03	-0.72
Property Plant And Equipment Net	-0.62	0.38	-0.41	-0.37	-0.39		0.08	-0.04	-0.45	-0.01	0.96	0.19	-0.73	-0.66	-0.41	-0.77	-0.17	0.2	0.05	-0.33	1.0	-0.73	0.64	0.25	-0.32	0.52
Net Debt	-0.4	0.18	-0.36	-0.72	0.05	0.08		0.47	0.14	-0.97	-0.02	-0.3	-0.35	-0.25	0.08	0.19	-0.19	-0.18	-0.47	-0.54	0.07	-0.36	-0.13	0.0	-0.59	-0.26
Retained Earnings	-0.19	-0.35	-0.74	-0.68	0.28	-0.04	0.47		0.4	-0.56	-0.25	-0.75	-0.09	-0.52	0.08	0.23	-0.27	-0.63	-0.96	-0.56	-0.04	-0.14	-0.32	0.11	-0.51	-0.56
Accounts Payable	0.18	-0.31	-0.27	-0.21	0.44	-0.45	0.14	0.4		-0.2	-0.54	-0.48	0.29	-0.16	0.54	0.42	-0.27	-0.32	-0.28	-0.28	-0.45	0.26	-0.44	-0.09	-0.13	-0.66
Cash	0.45	0.06	0.49	0.8	-0.08	-0.01	-0.97	-0.56	-0.2		0.13	0.49	0.37	0.27	-0.16	-0.17	0.26	0.19	0.57	0.63	-0.01	0.4	0.19	0.03	0.72	0.37
Non Current Assets Total	-0.49	0.54	-0.15	-0.15	-0.42	0.96	-0.02	-0.25	-0.54	0.13		0.46	-0.63	-0.51	-0.47	-0.74	-0.06	0.3	0.25	-0.14	0.96	-0.61	0.61	0.34	-0.11	0.65
Non Currrent Assets Other	0.25	0.69	0.75	0.65	-0.23	0.19	-0.3	-0.75	-0.48	0.49	0.46		0.12	0.3	-0.33	-0.14	0.31	0.41	0.72	0.56	0.19	0.17	0.09	0.37	0.64	0.58
Cash And Short Term Investments	0.98	0.01	0.62	0.65	0.68	-0.73	-0.35	-0.09	0.29	0.37	-0.63	0.12		0.42	0.24	0.85	-0.02	-0.14	0.19	0.38	-0.72	1.0	-0.43	-0.2	0.67	-0.39
Common Stock Total Equity	0.4	-0.02	0.73	0.67	-0.24	-0.66	-0.25	-0.52	-0.16	0.27	-0.51	0.3	0.42		-0.1	0.29	0.68	0.09	0.35	0.8	-0.66	0.45	-0.14	-0.34	0.55	0.21
Common Stock Shares Outstanding	0.17	-0.35	-0.13	-0.22	0.51	-0.41	0.08	0.08	0.54	-0.16	-0.47	-0.33	0.24	-0.1		0.34	-0.47	0.01	0.07	-0.41	-0.4	0.21	-0.42	-0.19	-0.19	-0.79
Short Term Investments	0.78	-0.02	0.38	0.24	0.77	-0.77	0.19	0.23	0.42	-0.17	-0.74	-0.14	0.85	0.29	0.34		-0.17	-0.25	-0.13	0.05	-0.76	0.83	-0.57	-0.23	0.3	-0.63
Non Current Liabilities Total	-0.03	0.25	0.38	0.43	-0.71	-0.17	-0.19	-0.27	-0.27	0.26	-0.06	0.31	-0.02	0.68	-0.47	-0.17		-0.28	0.03	0.84	-0.18	-0.01	0.15	-0.15	0.52	0.52
Other Current Assets	-0.04	0.05	0.3	0.17	0.0	0.2	-0.18	-0.63	-0.32	0.19	0.3	0.41	-0.14	0.09	0.01	-0.25	-0.28		0.67	-0.07	0.21	-0.08	0.28	-0.02	-0.11	0.3
Other Stockholder Equity	0.29	0.36	0.71	0.64	-0.04	0.05	-0.47	-0.96	-0.28	0.57	0.25	0.72	0.19	0.35	0.07	-0.13	0.03	0.67		0.4	0.06	0.24	0.29	-0.1	0.49	0.41
Total Liab	0.41	0.28	0.75	0.85	-0.4	-0.33	-0.54	-0.56	-0.28	0.63	-0.14	0.56	0.38	0.8	-0.41	0.05	0.84	-0.07	0.4		-0.34	0.41	0.06	-0.11	0.85	0.51
Property Plant And Equipment Gross	-0.6	0.38	-0.4	-0.37	-0.37	1.0	0.07	-0.04	-0.45	-0.01	0.96	0.19	-0.72	-0.66	-0.4	-0.76	-0.18	0.21	0.06	-0.34		-0.72	0.63	0.26	-0.31	0.52
Total Current Assets	0.98	0.03	0.66	0.69	0.67	-0.73	-0.36	-0.14	0.26	0.4	-0.61	0.17	1.0	0.45	0.21	0.83	-0.01	-0.08	0.24	0.41	-0.72		-0.41	-0.2	0.69	-0.35
Common Stock	-0.38	0.37	-0.07	-0.03	-0.43	0.64	-0.13	-0.32	-0.44	0.19	0.61	0.09	-0.43	-0.14	-0.42	-0.57	0.15	0.28	0.29	0.06	0.63	-0.41		-0.39	-0.03	0.68
Other Assets	-0.19	0.1	-0.08	-0.05	-0.08	0.25	0.0	0.11	-0.09	0.03	0.34	0.37	-0.2	-0.34	-0.19	-0.23	-0.15	-0.02	-0.1	-0.11	0.26	-0.2	-0.39		-0.05	0.13
Long Term Debt	0.72	0.46	0.82	0.91	0.03	-0.32	-0.59	-0.51	-0.13	0.72	-0.11	0.64	0.67	0.55	-0.19	0.3	0.52	-0.11	0.49	0.85	-0.31	0.69	-0.03	-0.05		0.27
Long Term Debt Total	-0.31	0.48	0.3	0.35	-0.72	0.52	-0.26	-0.56	-0.66	0.37	0.65	0.58	-0.39	0.21	-0.79	-0.63	0.52	0.3	0.41	0.51	0.52	-0.35	0.68	0.13	0.27

Click cells to compare fundamentals

Histogen Account Relationship Matchups

Histogen fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.9M	15.0M	27.2M	19.1M	17.2M	33.0M
Other Current Liab	440K	2.1M	764K	424K	381.6K	362.5K
Total Current Liabilities	1.4M	2.8M	2.3M	1.2M	1.1M	1.1M
Total Stockholder Equity	(37.1M)	7.9M	21.2M	14.4M	13.0M	16.4M
Property Plant And Equipment Net	415K	4.7M	4.8M	5.1M	5.9M	6.2M
Net Debt	(1.9M)	(1.5M)	(13.9M)	(7.5M)	(8.6M)	(9.0M)
Retained Earnings	(43.9M)	(62.7M)	(77.7M)	(88.3M)	(79.4M)	(83.4M)
Accounts Payable	808K	539K	1.4M	382K	343.8K	326.6K
Cash	2.1M	6.8M	18.7M	12.1M	10.9M	12.3M
Non Current Assets Total	484K	6.6M	5.6M	5.6M	6.5M	6.8M
Non Currrent Assets Other	69K	1.9M	805K	523K	601.5K	1.1M
Cash And Short Term Investments	2.1M	6.8M	18.7M	12.5M	11.3M	10.7M
Common Stock Shares Outstanding	590.7K	450.9K	1.9M	3.2M	2.9M	4.5M
Liabilities And Stockholders Equity	2.9M	15.0M	27.2M	19.1M	17.2M	33.0M
Non Current Liabilities Total	39.5M	5.3M	4.7M	4.5M	5.1M	4.9M
Other Current Assets	167K	1.2M	2.4M	848K	975.2K	1.4M
Other Stockholder Equity	(32.2M)	55.5M	98.8M	102.7M	92.4M	87.1M
Total Liab	40.9M	8.1M	7.1M	5.7M	5.1M	4.9M
Property Plant And Equipment Gross	221K	4.7M	4.8M	5.1M	5.9M	6.2M
Total Current Assets	2.5M	8.4M	21.6M	13.5M	12.1M	11.5M
Accumulated Other Comprehensive Income	(154.2K)	(34K)	(39.1M)	(15.0M)	(13.5M)	(12.8M)
Other Assets	69K	6.3M	805K	523K	601.5K	571.4K
Property Plant Equipment	415K	4.7M	4.8M	5.1M	5.9M	6.2M
Current Deferred Revenue	14.2M	10.1M	19K	48K	17.1K	16.2K
Net Receivables	110K	144K	165K	99K	89.1K	84.6K
Other Liab	138K	118K	112K	79K	71.1K	67.5K
Net Tangible Assets	(37.1M)	7.9M	21.2M	14.4M	16.6M	17.4M
Inventory	106K	300K	1.7M	400K	460K	716.7K

Pair Trading with Histogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Histogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will appreciate offsetting losses from the drop in the long position's value.

Moving against Histogen Stock

0.65	VTRS	Viatris	Pair Corr
0.53	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.52	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.43	WAT	Waters	Pair Corr

The ability to find closely correlated positions to Histogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Histogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Histogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Histogen to buy it.

The correlation of Histogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Histogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Histogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Histogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Histogen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Histogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Histogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Histogen Stock:

How To Invest In Histogen

Details

Is Histogen Stock a good investment?

Details

What is Histogen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.

You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Histogen. If investors know Histogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Histogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.81)

Revenue Per Share

0.004

Return On Assets

(0.54)

Return On Equity

(1.20)

The market value of Histogen is measured differently than its book value, which is the value of Histogen that is recorded on the company's balance sheet. Investors also form their own opinion of Histogen's value that differs from its market value or its book value, called intrinsic value, which is Histogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Histogen's market value can be influenced by many factors that don't directly affect Histogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Histogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Histogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Histogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Histogen Total Liab vs Non Currrent Assets Other Analysis

Total Liab vs Non Currrent Assets Other

Total Liab vs Non Currrent Assets Other Correlation Analysis

Correlation Coefficient

Total Liab

Non Currrent Assets Other

Histogen fundamental ratios Correlations

Histogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Histogen fundamental ratios Accounts

Pair Trading with Histogen

Moving against Histogen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Total Assets
Non Current Assets Total	+ 0.96	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.96	Non Current Assets Total

Cash	- 0.97	Net Debt
Other Stockholder Equity	- 0.96	Retained Earnings
Long Term Debt Total	- 0.79	Common Stock Shares Outstanding
Short Term Investments	- 0.77	Property Plant And Equipment Net
Property Plant And Equipment Gross	- 0.76	Short Term Investments
Non Currrent Assets Other	- 0.75	Retained Earnings